logo image
search icon
Neuroplasticity Market

Neuroplasticity Market Size, Share & Trends Analysis Report By Product Type (Software-Based Solutions, Hardware-Based Solutions), By Application (Stroke Rehabilitation, Traumatic Brain Injury (TBI) Rehabilitation, Neurodegenerative Disorders, Learning and Memory Enhancement, Mental Health Disorders), By End User, Region And Segment Forecasts, 2023-2031

Report ID : 2038 | Published : 2023-09-12 | Pages: 180 | Format: PDF/EXCEL

The Global Neuroplasticity Market Size is valued at USD 5.14 billion in 2022 and is predicted to reach USD 41.79 billion by the year 2031 at a 26.6% CAGR during the forecast period for 2023-2031.

Neuroplasticity Market

The capacity of the brain to reorganize itself by creating new neural connections as we age is known as neuroplasticity. The brain's neurons may adapt to various circumstances, pick up new skills, and react to environmental changes because of this process. Because it allows the neurons to rearrange themselves and form new connections, neuroplasticity is a crucial component in the brain's ability to recover from damage.

The brain can learn and store new knowledge by adapting to new experiences because of neuroplasticity. The term "plasticity" describes the brain's malleability or capacity for change, not its plasticity. Neuro is short for neurons, the nerve cells that comprise the brain and neurological system. Thus, neuroplasticity enables adjustments or changes in nerve cells. 

The term "neuroplasticity" describes how new experiences cause anatomical and functional changes in the brain. The brain can "rewire" and "reorganize" itself after brain trauma because of the plasticity of the brain, also known as neuroplasticity, as new connections are made and neural pathways to injured brain regions are cut off. Known as sprouting and rerouting, these processes are the main drivers of neuroplasticity. The process of sprouting is when nerve cells, or neurons, form new connections.

The high cost of the treatments and therapy is anticipated to hamper the market growth. Stringent regulatory procedures and a lack of reimbursement policies related to treatment hinder the growth of the market. Increasing mobile health applications and digital therapeutics creates opportunities to provide neuroplasticity interventions.

Recent Developments:

  • In Nov 2021, SFIO Starfleet Innotech, Inc. and biotech company NeuroSky signed an agreement granting the asset management company distribution rights to NeuroSky's cutting-edge health and wellness monitoring devices. As part of SFIO's initiative to create synergies across its primary investment areas, the company intends to sell an initial run of at least 100,000 wearables via partners in the health, construction, education, and other related industries.

Competitive Landscape

Some of the the neuroplasticity market players are:

  • NeuroSky Inc.
  • Posit Science Corporation
  • BrainHQ
  • Synaptitude Brain Health
  • Mindmaze SA
  • NeuroVigil Inc.
  • Lumosity
  • Neuronetics, Inc.
  • CogniFit
  • BrainHQ
  • Advanced Brain Monitoring
  • SharpBrains
  • Emotiv Inc.
  • BrainCo
  • BrainHQ
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc.

Market Segmentation:

The neuroplasticity market is segmented on the basis of product type, application, and end user. Product type includes software-based solutions and hardware-based solutions. Application segment includes stroke rehabilitation, traumatic brain injury (TBI) rehabilitation, neurodegenerative disorders, learning and memory enhancement, and mental health disorders. On the basis of end users, the market is segmented into hospitals and clinics, research institutes and academic centres, pharmaceutical and biotechnology companies, and others.

Based On Application, The Neurodegenerative Disorders Segment Is Accounted As A Substantial Contributor To The Neuroplasticity Market

The neurodegenerative disorders category is expected to hold a significant share of the global neuroplasticity market in 2022. Neuroplasticity, the brain's capability to reorganize and adapt, is crucial for brain rehabilitation and recovery in persons with neurodegenerative diseases, which is anticipated to drive market growth during the forecast period. New methods and treatments to promote neuroplasticity and recovery in patients with neurodegenerative diseases are anticipated to boost market expansion.

Hospitals And Clinics Segment To Witness Growth At A Rapid Rate

The hospitals and clinics category is projected to improve in the global neuroplasticity market. Increasing treatment related to neurological diseases is anticipated to drive market growth. Furthermore, technological advancements in medicine related to neurological disorders propel the market expansion.

In The Region, The North America Neuroplasticity Market Holds A Significant Revenue Share

The North America neuroplasticity market is expected to register the highest market share in revenue shortly. Increasing research and development in neuroplasticity treatments will drive market growth. Moreover, key market participants are focusing on acquisitions and mergers, which are driving the growth of the market.

Global Neuroplasticity Market Report Scope

Report Attribute

Specifications

Market size value in 2022

USD 5.14 Bn

Revenue forecast in 2031

USD 41.79 Bn

Growth rate CAGR

CAGR of 26.6 % from 2023 to 2031

Quantitative units

Representation of revenue in US$ Bn and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments covered

By Application, Product Type, End-user

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, Advanced Brain Monitoring, SharpBrains, Emotiv Inc., BrainCo, BrainHQ, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Neuroplasticity Market Snapshot

Chapter 4. Global Neuroplasticity Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Product Type:

5.2.1. Software-Based Solutions
5.2.2. Hardware-Based Solutions

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:

6.2.1. Stroke Rehabilitation
6.2.2. Traumatic Brain Injury (TBI) Rehabilitation
6.2.3. Neurodegenerative Disorders
6.2.4. Learning and Memory Enhancement
6.2.5. Mental Health Disorders

Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis
7.1. By End-user & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-user:

7.2.1. Hospitals and Clinics
7.2.2. Research Institutes and Academic Centers
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.4. Others

Chapter 8. Neuroplasticity Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Product Type, 2019-2031
8.1.2. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
8.1.3. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By End-user, 2019-2031
8.1.4. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Neuroplasticity Market revenue (US$ Million) By Product Type, 2019-2031
8.2.2. Europe Neuroplasticity Market revenue (US$ Million) By Application, 2019-2031
8.2.3. Europe Neuroplasticity Market revenue (US$ Million) By End-user, 2019-2031
8.2.4. Europe Neuroplasticity Market revenue (US$ Million) by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Product Type, 2019-2031
8.3.2. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Application, 2019-2031
8.3.3. Asia Pacific Neuroplasticity Market revenue (US$ Million) By End-user, 2019-2031
8.3.4. Asia Pacific Neuroplasticity Market revenue (US$ Million) by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2019-2031
8.4.2. Latin America Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.4.3. Latin America Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2019-2031
8.4.4. Latin America Neuroplasticity Market revenue (US$ Million) by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Neuroplasticity Market revenue (US$ Million) by country, 2019-2031

Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles

9.2.1. NeuroSky Inc
9.2.2. Posit Science Corporation
9.2.3. BrainHQ
9.2.4. Synaptitude Brain Health
9.2.5. Mindmaze SA
9.2.6. NeuroVigil Inc
9.2.7. Lumosity
9.2.8. Neuronetics, Inc.
9.2.9. CogniFit, BrainHQ
9.2.10. Advanced Brain Monitoring
9.2.11. SharpBrains
9.2.12. Emotiv Inc
9.2.13. BrainCo
9.2.14. BrainHQ
9.2.15. Neuroscape
9.2.16. Neuroplast BV
9.2.17. Reha Technology AG
9.2.18. Virtualware Group
9.2.19. Nexeon Medsystems Inc.

Segmentation of Neuroplasticity Market-

Neuroplasticity Market By Product Type

  • Software-Based Solutions
  • Hardware-Based Solutions

Neuroplasticity Market

Neuroplasticity Market By Application

  • Stroke Rehabilitation
  • Traumatic Brain Injury (Tbi) Rehabilitation
  • Neurodegenerative Disorders
  • Learning And Memory Enhancement
  • Mental Health Disorders.

Neuroplasticity Market By End User

  • Hospitals And Clinics
  • Research Institutes And Academic Centers
  • Pharmaceutical And Biotechnology Companies
  • Others

Neuroplasticity Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.4456

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Neuroplasticity Market Size?

The Global Neuroplasticity Market is expected to grow at a 26.6% CAGR during the forecast period for 2023-2031.

NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, Brai

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach